We are proud to announce that #Surge, supported by #LallianSe since late 2021, made the cover of #NatureBiotechnology this month with their groundbreaking paper, “Discovery of sparse and reliable omics biomarkers with Stabl”.
🚀 We are delighted to announce that #Surge, supported by #LallianSe since the end of 2021 has just conpleted its second fundraising of €7.5M ! 🚀
For more than two years we have worked closely alongside #Surge leaders on the issues of #fundraising and execution of an attractive and coherent #equitystory as a #SparringPartner. But what is a “Sparring Partner”?
He is above all a #partner. With a tailor-made approach and in a relationship of equals, we support, manage, question, strengthen and explore strategies and their implementation together.
🚀 We are delighted to announce that SurgeCare has just completed its first fundraising of €2.5M and concluded an exclusive licensing agreement with Stanford!
For 9 months LallianSe has been working alongside Surge managers as a “Sparring Partner” on fundraising/equity story issues. “Sparring Partner”: what is it?
➡️Tailored support for the management team in its strategic orientations ➡️Support also in the management, coordination and animation of governance ➡️Access to our network of Experts and Entrepreneurs in residence
🧠 The brain is mysterious. There is much to explore…
From their #manifesto to the launch of their #podcast, “The White Side of the Brain,” with inspiring conversations from leaders who will share their visions and expertise, BrainTale is at the forefront of innovation in brain health!
A big thank you to our #Experts LallianSe Anna, Laura & Shahrzad for helping to design these two projects and congratulations to the entire #TeamBraintale for their commitment.
In this great momentum, during June Julie Rachline was able to anchor our proximity with the Région Grand Est during #NextmedDay, an event dedicated to collaborative innovation and the promotion of innovative projects in the field of health.
Supported by BioValley France, Nextmed Strasbourg and in particular Quest for health among others, the event allowed participants to identify the issues linked to the “Major challenges and themes #France2030“.
Alongside Bruno FERRY, Economic Advisor in artificial and digital intelligence at DREETS Grand-Est, Julie spoke with the hat of #CEO BrainTale. They were able to discuss the major advances and opportunities offered by #AI and diagnostics in the service of health.
This week we traveled back in time… A few days ago we answered the question “what will the hospital of tomorrow look like?”. Today, Julie inaugurated the brand new podcast project of the GROUPE MACSF by answering a more general question: how to improve the health of tomorrow?
Julie was able to present a future in which, thanks to a better knowledge of the brain, BrainTale will allow us to anticipate, prevent and adjust our care pathways and our preventive vision to improve our brain health.
📣 We were proud to share the #successstory of #BrainTale, which announced its fundraising of 4.5 million euros !
Co-founded and accompanied by LallianSe from 2018, then by ensuring the General Management of the #startup since 2020 by Julie Rachline, the relationship between LallianSe and BrainTale is today:
+6 years of collaboration 8 Experts from our network 2 products on the market EU & US expansion
And above all a successful first institutional fundraiser!
This #success is our daily driving force, which illustrates our know-how and #commitment to transforming innovations into economic success.
Finally, in partnership with the CNRS, the Alliancy editorial team offered to present BrainTale, LallianSe’s flagship initiative and Deeptech spin-off start-up from AP-HP, in a female panel around Antoine Petit, CEO of the CNRS, on the institute’s strategy in terms of promoting public research whose respective markets (health, quantum and industry) concern the major challenges of tomorrow. Watch the replay below:
November 2022
BioFIT Event is the leading #event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. It is also the European marketplace for seed capital and venture capital investment in Life Sciences.
It is in particular with her #BrainTaleCEO‘s cap that Julie Rachline was present. Indeed, LallianSe builds, develops and manages the equity story of BrainTale, our flagship initiative since 2016 :
– Cofounding of the company with Vincent Perlbarg, Didier Cassereau, Louis Puybasset, Damien Galanaud & Velly Lionel, – Integration and reinforcement of the team, – Accommodation in hospital coworking, – Management of experts and entrepreneurs in residence, – Fundraising…
Braintale, our flagship project, is actually part of the 8 startup winners of the #FrenchHealthcareBooster Germany 2022, announced the launch of #BrainTaleCarewith the CE of IIa class label of his two moduls, and ended the month by being quoted by Challenges in the Medtech & Biotech section as one of the 100 start-ups in which to invest in 2022 ! Congratulations to #BrainTale !
April 2021
Do you speak LallianSe ? #5 Vincent Perlbarg & Julie Rachline I Braintale I
Fabentech continues its trajectory and completes the first steps of its #equitystory !
A French #biopharmaceutical company specializing in the development and production of therapeutic products against biological threats, Fabentech has just announced support of up to €20M from the European Investment Bank (EIB) through #HERAInvest program.
Beyond strengthening #R&D capacities, this allows to increase industrial efforts and international impact. A key step forward in global preparedness against biological and bioterrorist threats.
Happy to have finalized this transaction with Jeremy Ballet.
👏 We take on challenges together, and celebrate victories together. Congratulations to Sébastien IVA and the entire team for this major milestone.
Initiated as #SparringPartner following the arrival of Sébastien IVA as Chairman of the Management Board in 2020, the translation of the vision, the outline of the roadmap and the articulation of the investment thesis have gradually strengthened the agenda of interactions and existing support.
A real pleasure to support the evolution of #Fabentech towards its position as European leader!
Remember, a few weeks ago we announced the renewal of our #collaboration with the Rare Diseases Foundation, das part of the co-design workshops in e-health & rare diseases. Julie Rachline was able to contribute her #expertise to the ‘SCLER-AIME’ project, named winner this year.
The opportunity for us to take stock of our partnership. For what ?!
🎯 To align our objectives and values, our efforts are guided by a shared vision: offering concrete and sustainable solutions to the complex challenges posed by #rarediseases.
🚀 To prepare for the future together, anticipate future challenges and issues to come and enable better health for as many people as possible.
For the 3rd consecutive year, Julie contributed to the co-design workshops in e-health & rares diseases organized by the Rare Diseases Foundation.
At #LallianSe, our #experience in constructing investment theses allows us to highlight the most relevant dimensions and milestones of each project, thus providing necessary insight and value creation for investors.
Remember, we announced to you at the beginning of the year the renewal of our #collaboration with the Rare Diseases Foundation as part of the co-design workshops in e-health & rare diseases for projects in the early study phase.
What are the objectives of these workshops?
🎯 Help in the initiation of innovative projects by identifying the necessary resources and key steps for their implementation 🎯 Adopt a collaborative approach and stimulate inter-business dialogue from the first ideas 🎯 Promote discussions with partners and Experts who master the subject
Why is this important to us?
💪 To encourage the emergence of innovations driven by healthcare professionals 🙌 To support the improvement of the care and life path of people suffering from a rare disease 🤝 To be consistent with our values and our field initiatives
It is as a LallianSe Expert that Julie Rachline was able to bring her #expertise to the ‘Brain Mouv’ project led by Iris Marolleau.
For 3 years already, led by Emmanuelle Deponge, a LallianSe Expert, involved in the selection of projects, #NBGH has entrusted us with the 360° Sessions in a format specifically organized to meet the challenges of the program
These sessions do not just challenge all of the company’s development areas. They also aim to build the foundations of the #equitystory for the development of business projects!
March 2023
At LallianSe, each support is tailor-made,flexible and agile to meet the key development challenges of our clients and partners, here with NBGH
#NBGH asked #LallianSe to pilot the « 360° Sessions » at the instigation of Emmanuelle Deponge, involved in the selection of projects while being #LallianSe Expert for several years.
These sessions challenge all areas of business development: from planning to execution, from regulatory strategy to organization, thanks to LallianSe’s unique track record and Emmanuelle’s #expertise.
Very happy to share today this excellente news for the development of #Biomunex.
For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.
Congratulations to the entire team for starting this clinical study ! 👏
What analogies between artistic creation and innovation? How can we draw inspiration from artistic creativity in our daily lives as entrepreneurs?
In accordance with our #values, and through our #atypical approach, LallianSe has taken the initiative to stimulate a privileged dialogue with Gérard Garouste, one of the most important contemporary painters, by organizing an exclusive and unique event: a one-to-one and a visit to his retrospective at the Centre Pompidou, which you can visit until 2023 January 2.
Transmission, perseverance, resilience and ambition – qualities and values highlighted by Gérard Garouste, which are perfectly reflected in our daily lives as entrepreneurs, researchers and other players in the world of healthcare innovation.
Thanks to Gérard and the #AssociationLaSource for this suspended moment and these nods to our #Embûches de l’Innovation, beyond being an essential source of inspiration for an enthusiastic future.
